- CA$7.72m
- CA$6.46m
- CA$1.59m
- 17
- 28
- 23
- 12
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.23 | ||
| Price to Tang. Book | 3.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.77 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -255.46% | ||
| Return on Equity | -178.18% | ||
| Operating Margin | -604.27% | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | 1.1 | 0.66 | 1.59 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Scryb Inc. is a technology company, which provides its platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights. Its platform enables customers across industries to create, enhance and power disruptive solutions. Its technology includes Cybeats, Fionet and Pharmatrac. Cybeats is an integrated security platform designed to secure and protect connected devices. Cybeats approach eliminates device downtime due to cyber-attacks and allows device manufacturers to develop and maintain secure and protected devices. Fionet Platform is an end-to-end, rapid testing and tracking solution for community-based or decentralized settings. Fionet Platform handles scheduling and registration via phone app at home, on-site check-in, rapid, on-the-spot antigen testing and anonymized data and stats for dashboards for authorized stakeholders. Pharmatrac is an artificial intelligence healthcare company that provides insight into medication behavior.
Directors
- Last Annual
- September 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 29th, 2014
- Public Since
- November 8th, 1988
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Canadian Securities Exchange- Shares in Issue
- 257,282,672
- Address
- 65 International Blvd, Suite 202, TORONTO, M9W 6L9
- Web
- https://www.scryb.ai
- Phone
- +1 6478729982
- Auditors
- Jackson & Co., LLP
Upcoming Events for SCYB
Scryb Inc Annual Shareholders Meeting
Q2 2024 Scryb Inc Earnings Release
Similar to SCYB
Aquarius Surgical Technologies
Canadian Securities Exchange
Cannabix Technologies
Canadian Securities Exchange
Cognetivity Neurosciences
Canadian Securities Exchange
Gemina Laboratories
Canadian Securities Exchange
Izotropic
Canadian Securities Exchange
FAQ
What is the Scryb share price?
As of Today at 19:19 UTC, shares in Scryb are trading at CA$0.03. This share price information is delayed by 15 minutes.
How has the Scryb share price performed this year?
Shares in Scryb last closed at CA$0.03 and the price had moved by -71.43% over the past 365 days. In terms of relative price strength the Scryb share price has underperformed the Toronto Stock Exchange 300 Composite Index by -72.89% over the past year.
What are the analyst and broker recommendations for Scryb?
The overall consensus recommendation for Scryb is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Scryb dividend yield?
Scryb does not currently pay a dividend.
Does Scryb pay a dividend?
Scryb does not currently pay a dividend.
When does Scryb next pay dividends?
Scryb does not currently pay a dividend.
How do I buy Scryb shares?
To buy shares in Scryb you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Scryb?
As of the previous close price of CA$0.03, shares in Scryb had a market capitalisation of CA$7.72m.
Where are Scryb shares listed?
Here are the trading details for Scryb:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: SCYB
What kind of share is Scryb?
Based on an overall assessment of its quality, value and momentum Scryb is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Scryb share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Scryb share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Scryb. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -25.14%.
As of the last closing price of CA$0.03, shares in Scryb were trading -33.22% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Scryb PE Ratio?
The Scryb PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Scryb?
We do not have data on Scryb's directors